We purified and characterized a novel peptide from the venom of the fi
sh-hunting cone snail Conus striatus that inhibits voltage-gated K+ ch
annels. The peptide, kappa A-conotoxin SIVA, causes characteristic spa
stic paralytic symptoms when injected into fish, and in frog nerve-mus
cle preparations exposed to the toxin, repetitive action potentials ar
e seen in response to a single stimulus applied to the motor nerve. Ot
her electrophysiological tests on diverse preparations provide evidenc
e that is consistent with the peptide blocking K+ channels. The peptid
e has three disulfide bonds; the locations of Cys residues indicate th
at the spastic peptide may be the first and defining member of a new f
amily of Conus peptides, the kappa A-conotoxins, which are structurall
y related to, but pharmacologically distinct from, the alpha A-conotox
ins. This 30 AA tricyclic toxin has several characteristics not previo
usly observed in Conus peptides. In addition to the distinctive biolog
ical and physiological activity, a novel biochemical feature is the un
usually long linear N-terminal tail (11 residues) which contains one O
-glycosylated serine at position 7. This is the first evidence for O-g
lycosylation as a posttranslational modification in a biologically act
ive Conus peptide.